Gangolli Julian S - Insider Non-Derivative Transactions at Revance Therapeutics, Inc. (RVNC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 1, 2024, Gangolli Julian S's relationship to Revance Therapeutics, Inc. (RVNC) is Director, and currently has 45,106 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RVNC insiders.
Data Source: SEC.
Gangolli Julian S - Insider Non-Derivative Transactions of RVNC Common Stock
Gangolli Julian S - Insider Non-Derivative Transactions at RVNC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 2, 2024 | Acquisition -- (Common Stock) | 15000 | 0 | 45106 |
| May 4, 2023 | Acquisition -- (Common Stock) | 3534 | 0 | 30106 |